| Metric | შპს მედ ფარმასი გრუპი | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾1.2m₾1.5m | ₾2.70bn₾2.32bn |
| Revenue growth | -19.6% | 16.6% |
| Profitability | ||
| EBITDA | -₾11k-₾565k | — |
| EBITDA margin | -0.9%-38.3% | — |
| Net profit | -₾48k-₾582k | ₾1.84bn₾1.33bn |
| Net margin | -4.1%-39.5% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾892k₾1.1m | ₾39.27bn₾31.39bn |
| Total equity | ₾672k₾720k | ₾5.63bn₾4.45bn |
| ROE | -7.2%-80.9% | 32.6%30.0% |